Understand the source comparison
GHRP-2 Acetate Myths Debunked: Comparison
The following table contrasts common myths about GHRP-2 acetate with evidence-based realities, highlighting the mechanistic basis for each correction and the practical research implication. GHRP-2 is the same as injecting growth hormone GHRP-2 stimulates endog
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The following table contrasts common myths about GHRP-2 acetate with evidence-based realities, highlighting the mechanistic basis for each correction and the practical research implication.
- GHRP-2 is the same as injecting growth hormone
- GHRP-2 stimulates endogenous pulsatile GH release; exogenous GH bypasses the pituitary entirely
- GHRP-2 binds ghrelin receptors (GHS-R1a) on somatotrophs, triggering natural GH secretion with intact negative feedback
- Subjects with pituitary dysfunction will show minimal response to GHRP-2 but normal response to exogenous GH
- GHRP-2 works independently of diet and training
- GH effects are conditional on insulin sensitivity, substrate availability, and mechanical tension
- GH-stimulated lipolysis requires low insulin; mTOR-driven protein synthesis requires leucine threshold + resistance training
- Fasted-state administration and adequate protein intake (1.6–2.2 g/kg) are non-negotiable for meaningful outcomes
- Reconstituted GHRP-2 is stable at room temperature
- Reconstituted peptides denature rapidly above 8°C, losing receptor binding affinity
- Heat disrupts hydrogen bonds and tertiary structure, preventing ghrelin receptor binding
- Refrigeration at 2–8°C post-reconstitution is mandatory; temperature excursions render peptides inactive without visible change
- All subjects respond identically to GHRP-2
- Response magnitude depends on baseline pituitary function, IGF-1 levels, age, and metabolic health
- Somatotroph cell mass and GH reserve decline with age; insulin resistance blunts downstream IGF-1 signaling
- Younger subjects with healthy metabolic profiles show 2–3× greater GH pulse amplitude than older or insulin-resistant subjects